Hypoxia and its therapeutic possibilities in paediatric cancers

C Bernauer, YKS Man, JC Chisholm… - British journal of …, 2021 - nature.com
In tumours, hypoxia—a condition in which the demand for oxygen is higher than its
availability—is well known to be associated with reduced sensitivity to radiotherapy and …

Introducing fluorescence-guided surgery for pediatric Ewing, osteo-, and rhabdomyosarcomas: a literature review

Z Rijs, B Jeremiasse, N Shifai, H Gelderblom, CFM Sier… - Biomedicines, 2021 - mdpi.com
Sarcomas are a rare heterogeneous group of malignant neoplasms of mesenchymal origin
which represent approximately 13% of all cancers in pediatric patients. The most prevalent …

GLUT-1 as a predictor of worse prognosis in pancreatic adenocarcinoma: immunohistochemistry study showing the correlation between expression and survival

M Achalandabaso Boira, M Di Martino, C Gordillo… - BMC cancer, 2020 - Springer
Background Various parameters have been considered for predicting survival in pancreatic
ductal adenocarcinoma. Information about western population is missing. The aim of this …

Correlations between DWI, IVIM, and HIF‐1α expression based on MRI and pathology in a murine model of rhabdomyosarcoma

Z Yin, X Li, Y Zhang, J Tao, Y Yang… - Magnetic …, 2022 - Wiley Online Library
Purpose To investigate the correlation between DWI, intravoxel incoherent motion (IVIM),
and hypoxia‐inducible factor 1‐alpha (HIF‐1α) expression in a nude mouse model of …

[HTML][HTML] A bioengineering method for modeling alveolar Rhabdomyosarcoma and assessing chemotherapy responses

E Stefanek, E Samiei, M Kavoosi, M Esmaeillou… - MethodsX, 2021 - Elsevier
Rhabdomyosarcoma (RMS) is the most common pediatric soft-tissue malignant tumor.
Treatment of RMS usually includes primary tumor resection along with systemic …

The Capacity of Drug-Metabolising Enzymes in Modulating the Therapeutic Efficacy of Drugs to Treat Rhabdomyosarcoma

EA Picher, M Wahajuddin, S Barth, J Chisholm… - Cancers, 2024 - mdpi.com
Simple Summary Rhabdomyosarcoma is a rare type of childhood cancer. Current treatment
options include surgery, radiotherapy, and chemotherapy. Survival chances for RMS …

[HTML][HTML] The PD-L1/PD-1 axis expression on tumor-infiltrating immune cells and tumor cells in pediatric rhabdomyosarcoma

A Gabrych, R Pęksa, M Kunc, M Krawczyk… - … -Research and Practice, 2019 - Elsevier
Background Activation of immune checkpoints, eg PD-1/PD-L1 axis, in cancer
microenvironment, enables evasion of host anti-cancer immune response and drives tumor …

High expression of solute carrier family 2 member 1 (SLC2A1) in cancer cells is an independent unfavorable prognostic factor in pediatric malignant peripheral nerve …

MA Krawczyk, M Kunc, M Styczewska, A Gabrych… - Diagnostics, 2021 - mdpi.com
Malignant peripheral nerve sheath tumor (MPNST) in children is a rare mesenchymal
malignancy developing predominantly in the setting of neurofibromatosis type 1. The …

Splice-switching of the insulin receptor pre-mRNA alleviates tumorigenic hallmarks in rhabdomyosarcoma

S Khurshid, M Montes, DF Comiskey Jr… - NPJ Precision …, 2022 - nature.com
Rhabdomyosarcoma (RMS) is an aggressive pediatric tumor with a poor prognosis for
metastasis and recurrent disease. Large-scale sequencing endeavors demonstrate that …

The molecular pathology of eye tumors: A 2019 update main interests for routine clinical practice

S Nahon-Esteve, A Martel, C Maschi… - Current Molecular …, 2019 - ingentaconnect.com
Over the last few years, we have seen constant development of molecular pathology for the
care of patients with cancer. The information obtained from molecular data has transformed …